Framework for establishing integrated kidney care programs in low- and middle-income countries.

chronic dialysis kidney-failure low- and middle-income country noncommunicable disease palliation transplantation

Journal

Kidney international supplements
ISSN: 2157-1724
Titre abrégé: Kidney Int Suppl (2011)
Pays: United States
ID NLM: 101562008

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 26 06 2019
revised: 07 11 2019
accepted: 08 11 2019
entrez: 10 3 2020
pubmed: 10 3 2020
medline: 10 3 2020
Statut: ppublish

Résumé

Secular increases in the burden of kidney failure is a major challenge for health systems worldwide, especially in low- and middle-income countries (LMICs) due to growing demand for expensive kidney replacement therapies. In LMICs with limited resources, the priority of providing kidney replacement therapies must be weighed against the prevention and treatment of chronic kidney disease, other kidney disorders such as acute kidney injury, and other noncommunicable diseases, as well as other urgent public health needs. Kidney failure is potentially preventable-not just through primary prevention of risk factors for kidney disease such as hypertension and diabetes, but also by timely management of established chronic kidney disease. Among people with established or incipient kidney failure, there are 3 key treatment strategies-conservative care, kidney transplantation, and dialysis-each of which has its own benefits. Joining up preventive care for people with or at risk for milder forms of chronic kidney disease with all 3 therapies for kidney failure (and developing synergistic links between the different treatment options) is termed "integrated kidney care" and has potential benefits for patients, families, and providers. In addition, because integrated kidney care implicitly considers resource use, it should facilitate a more sustainable approach to managing kidney failure than providing one or more of its components separately. There is currently no agreed framework that LMIC governments can use to establish and/or scale up programs to prevent and treat kidney failure or join up these programs to provide integrated kidney care. This review presents a suggested framework for establishing integrated kidney care programs, focusing on the anticipated needs of policy makers in LMICs.

Identifiants

pubmed: 32149006
doi: 10.1016/j.kisu.2019.11.002
pii: S2157-1716(19)30016-4
pmc: PMC7031683
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e19-e23

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Informations de copyright

© 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Références

Am J Transplant. 2011 Oct;11(10):2093-109
pubmed: 21883901
Kidney Int. 2016 Nov;90(5):916-920
pubmed: 27742191
Transplantation. 2017 Aug;101(8S Suppl 1):S1-S109
pubmed: 28742762
Kidney Int. 2016 Dec;90(6):1164-1174
pubmed: 27884311
Lancet. 2017 Mar 25;389(10075):1238-1252
pubmed: 27887750
BMC Health Serv Res. 2015 Nov 12;15:506
pubmed: 26563300
Lancet Glob Health. 2017 Apr;5(4):e408-e417
pubmed: 28229924
Kidney Int. 2019 Apr;95(4S):S1-S33
pubmed: 30904051
J Clin Med Res. 2017 Feb;9(2):104-116
pubmed: 28090226
Nephrol Dial Transplant. 2016 Jun;31(6):868-74
pubmed: 27217391
Perit Dial Int. 2017 Mar-Apr;37(2):155-158
pubmed: 28360366
Kidney Int. 2011 Dec;80(12):1258-70
pubmed: 21993585
Nephrol Dial Transplant. 2013 Oct;28(10):2553-69
pubmed: 23737482

Auteurs

Marcello Tonelli (M)

Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Pan American Health Organization/World Health Organization's Collaborating Centre in Prevention and Control of Chronic Kidney Disease, University of Calgary, Calgary, Alberta, Canada.

Victoria Nkunu (V)

Department of Medicine, University of Calgary, Calgary, Alberta, Canada.

Cherian Varghese (C)

World Health Organization, Geneva, Switzerland.

Ali K Abu-Alfa (AK)

Division of Nephrology and Hypertension, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.

Mona N Alrukhaimi (MN)

Department of Medicine, Dubai Medical College, Dubai, United Arab Emirates.

Louise Fox (L)

Green Fox Consulting Ltd., Oxford, UK.

John Gill (J)

Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

David C H Harris (DCH)

Centre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.

Fan Fan Hou (FF)

State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Philip J O'Connell (PJ)

Renal Unit, University of Sydney at Westmead Hospital, Sydney, New South Wales, Australia.
Westmead Clinical School, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.

Harun Ur Rashid (HU)

Department of Nephrology, Kidney Foundation Hospital and Research Institute, Dhaka, Bangladesh.

Abdou Niang (A)

Department of Nephrology, Dalal Jamm Hospital, Cheikh Anta Diop University Teaching Hospital, Dakar, Senegal.

Shahrzad Ossareh (S)

Division of Nephrology, Department of Medicine, Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.

Vladimir Tesar (V)

Department of Nephrology, General University Hospital, Charles University, Prague, Czech Republic.

Elena Zakharova (E)

Department of Nephrology, Moscow City Hospital named after S.P. Botkin, Moscow, Russian Federation.
Department of Nephrology, Moscow State University of Medicine and Dentistry, Moscow, Russian Federation.
Department of Nephrology, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation.

Chih-Wei Yang (CW)

Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.

Classifications MeSH